In GSCs the compound, tested at 1 μM, decreased LDH-A transcription as well, with a higher rate of reduction than that observed in the GBM cells, consistent with the data reported in adenocarcinoma CSCs25. This evidence concerns the gene LDHA and glioblastoma.